Drugs / Depiwhite Serum
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07071363 | Jun → Oct 2025 overdue | hyperpigmentation of the skin | Laboratoire Dermatologique ACM | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Depiwhite Serum | “Group 1: Apply a morning routine (Depiwhite Serum + Depiwhite M SPF50+ cream) Apply an evening routine (Depiwhite Serum + Placebo Cream without Hydroquinone)” NCT07071363 ↗ |
| Modality | Other / unclassified | “a depigmenting cosmetic serum with non-drug actives” NCT07071363 ↗ |
| Route | Topical | “All products are applied topically” NCT07071363 ↗ |